Geniposide attenuates insulin-deficiency-induced acceleration of β-amyloidosis in an APP/PS1 transgenic model of Alzheimer's disease

Neurochemistry International

Volumn 89, Issue , 2015, Pages 7-16

  Zhang, Yonglan ^a,b   Yin, Fei ^a,c   Liu, Jianhui ^a,c   Liu, Zixuan ^c   Guo, Lixia ^c   Xia, Zhining ^a   Zidichouski, Jeffrey ^d  

^a CHONGQING UNIVERSITY   (China)

^b CHONGQING UNIVERSITY OF TECHNOLOGY   (China)

^c Business University   (China)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

Alzheimers disease (AD); b amyloid (Ab); Diabetes; Geniposide; Insulin signaling; Secretase

Indexed keywords

ADAM10 ENDOPEPTIDASE; ALPHA SECRETASE; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE 1; GENIPOSIDE; INSULIN; INSULINASE; LIRAGLUTIDE; PRESENILIN 1; STREPTOZOCIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); IRIDOID; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL CULTURE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN DEFICIENCY; MOUSE; MOUSE MODEL; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TRANSGENIC ORGANISM; TREATMENT DURATION; UPREGULATION; WILD TYPE; ANIMAL; BRAIN; C57BL MOUSE; CELL CULTURE; DEFICIENCY; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODEL; DRUG EFFECTS; GENETICS; HUMAN; MALE; METABOLISM;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; HUMANS; INSULIN; IRIDOIDS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; PRESENILIN-1;

EID: 84942296710     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2015.04.002     Document Type: Article

References (46)

1. Ahmad W. Overlapped metabolic and therapeutic links between Alzheimer and diabetes Mol. Neurobiol 47 2013 399 424
2. Beeri M.S., Schmeidler J., Silverman J.M., Gandy S., Wysocki M., Hannigan C.M., and et al. Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology Neurology 71 2008 750 757
3. Bian L., Yang J.D., Guo T.W., Sun Y., Duan S.W., Chen W.Y., and et al. Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese Neurology 63 2004 241 245
4. Biessels G.J., Bravenboer B., and Gispen W.H. Glucose, insulin and the brain: modulation of cognition and synaptic plasticity in health and disease: a preface Eur. J. Pharmacol 490 2004 1 4
5. Biessels G.J., Kappelle L.J. Utrecht Diabetic Encephalopathy Study Group Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem. Soc. Trans 33 2005 1041 1044
6. Brindle N., and George-Hyslop P.S. The genetics of Alzheimer's disease Methods Mol. Med 32 2000 23 43
7. Checler F., and Turner A.J. Journal of Neurochemistry special issue on Alzheimer's disease: 'amyloid cascade hypothesis-20 years on' J. Neurochem 120 Suppl. 1 2012 iii iv
8. Cole G.M., and Frautschy S.A. The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's Disease Exp. Gerontol 42 2007 10 21
9. Correia S.C., Santos R.X., Carvalho C., Cardoso S., Candeias E., Santos M.S., and et al. Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation Brain Res 1441 2012 64 78
10. Devi L., Alldred M.J., Ginsberg S.D., and Ohno M. Mechanisms underlying insulin deficiency-induced acceleration of beta-amyloidosis in a mouse model of Alzheimer's disease PLoS ONE 7 2012 e32792
11. Dominguez R.O., Marschoff E.R., Guareschi E.M., Repetto M.G., Famulari A.L., Pagano M.A., and et al. Insulin, glucose and glycated hemoglobin in Alzheimer's and vascular dementia with and without superimposed Type II diabetes mellitus condition J. Neural Transm 115 2008 77 84
12. Freiherr J., Hallschmid M., Frey W.H. 2nd, Brunner Y.F., Chapman C.D., Holscher C., and et al. Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence CNS Drugs 27 2013 505 514
13. Gao C., Liu Y., Jiang Y., Ding J., and Li L. Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3beta pathway in streptozotocin-induced alzheimer rat model Brain Pathol 24 2014 261 269
14. Gengler S., Hamilton A., and Holscher C. Synaptic plasticity in the hippocampus of a APP/PS1 mouse model of Alzheimer's disease is impaired in old but not young mice PLoS ONE 5 2010 e9764
15. Grunblatt E., Koutsilieri E., Hoyer S., and Riederer P. Gene expression alterations in brain areas of intracerebroventricular streptozotocin treated rat J. Alzheimers Dis 9 2006 261 271
16. Guo L.X., Liu J.H., and Xia Z.N. Geniposide inhibits CoCl2-induced PC12 cells death via the mitochondrial pathway Chin. Med. J. (Engl.) 122 2009 2886 2892
17. Guo L.X., Xia Z.N., Gao X., Yin F., and Liu J.H. Glucagon-like peptide 1 receptor plays a critical role in geniposide-regulated insulin secretion in INS-1 cells Acta Pharmacol. Sin 33 2012 237 241
18. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
19. Hardy J.A., and Higgins G.A. Alzheimer's disease: the amyloid cascade hypothesis Science 256 1992 184 185
20. Hemming M.L., Patterson M., Reske-Nielsen C., Lin L., Isacson O., and Selkoe D.J. Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease PLoS Med 4 2007 e262
21. Holscher C. Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease Biochem. Soc. Trans 39 2011 891 897
22. Hoyer S. Glucose metabolism and insulin receptor signal transduction in Alzheimer disease Eur. J. Pharmacol 490 2004 115 125
23. Li L., and Holscher C. Common pathological processes in Alzheimer disease and type 2 diabetes: a review Brain Res. Rev 56 2007 384 402
24. Liu J., Zheng X., Yin F., Hu Y., Guo L., Deng X., and et al. Neurotrophic property of geniposide for inducing the neuronal differentiation of PC12 cells Int. J. Dev. Neurosci 24 2006 419 424
25. Liu J., Yin F., Zheng X., Jing J., and Hu Y. Geniposide, a novel agonist for GLP-1 receptor, prevents PC12 cells from oxidative damage via MAP kinase pathway Neurochem. Int 51 2007 361 369
26. Liu J., Guo L., Yin F., Zhang Y., Liu Z., and Wang Y. Geniposide regulates glucose-stimulated insulin secretion possibly through controlling glucose metabolism in INS-1 cells PLoS ONE 8 2013 e78315
27. Liu J., Zhang Y., Deng X., and Yin F. Geniposide decreases the level of Abeta1-42 in the hippocampus of streptozotocin-induced diabetic rats Acta Biochim. Biophys. Sin. (Shanghai) 45 2013 787 791
28. Liu J.H., Yin F., Guo L.X., Deng X.H., and Hu Y.H. Neuroprotection of geniposide against hydrogen peroxide induced PC12 cells injury: involvement of PI3 kinase signal pathway Acta Pharmacol. Sin 30 2009 159 165
29. Liu Y., Liu F., Grundke-Iqbal I., Iqbal K., and Gong C.X. Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes J. Pathol 225 2011 54 62
30. Long-Smith C.M., Manning S., McClean P.L., Coakley M.F., O'Halloran D.J., Holscher C., and et al. The diabetes drug liraglutide ameliorates aberrant insulin receptor localisation and signalling in parallel with decreasing both amyloid-beta plaque and glial pathology in a mouse model of Alzheimer's disease Neuromolecular Med 15 2013 102 114
31. Luchsinger J.A. Insulin resistance, type 2 diabetes, and AD: cerebrovascular disease or neurodegeneration? Neurology 75 2010 758 759
32. Lv C., Liu X., Liu H., Chen T., and Zhang W. Geniposide attenuates mitochondrial dysfunction and memory deficits in APP/PS1 transgenic mice Curr. Alzheimer Res 11 2014 580 587
33. Miners J.S., Baig S., Palmer J., Palmer L.E., Kehoe P.G., and Love S. Abeta-degrading enzymes in Alzheimer's disease Brain Pathol 18 2008 240 252
34. Moloney A.M., Griffin R.J., Timmons S., O'Connor R., Ravid R., and O'Neill C. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling Neurobiol. Aging 31 2010 224 243
35. Moreira P.I. Alzheimer's disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin J. Alzheimers Dis 30 Suppl. 2 2012 S199 S215
36. Moreira P.I., Santos M.S., Seica R., and Oliveira C.R. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes J. Neurol. Sci 257 2007 206 214
37. Negishi T., Ishii Y., Kyuwa S., Kuroda Y., and Yoshikawa Y. Inhibition of staurosporine-induced neuronal cell death by bisphenol A and nonylphenol in primary cultured rat hippocampal and cortical neurons Neurosci. Lett 353 2003 99 102
38. Ohno M. Failures to reconsolidate memory in a mouse model of Alzheimer's disease Neurobiol. Learn. Mem 92 2009 455 459
39. Ohno M., Chang L., Tseng W., Oakley H., Citron M., Klein W.L., and et al. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1 Eur. J. Neurosci 23 2006 251 260
40. Okura Y., Kohyama K., Park I.K., and Matsumoto Y. Nonviral DNA vaccination augments microglial phagocytosis of beta-amyloid deposits as a major clearance pathway in an Alzheimer disease mouse model J. Neuropathol. Exp. Neurol 67 2008 1063 1071
41. Qiu W.Q., and Folstein M.F. Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis Neurobiol. Aging 27 2006 190 198
42. Ristow M. Neurodegenerative disorders associated with diabetes mellitus J. Mol. Med. (Berl.) 82 2004 510 529
43. Solas M., Aisa B., Mugueta M.C., Del Rio J., Tordera R.M., and Ramirez M.J. Interactions between age, stress and insulin on cognition: implications for Alzheimer's disease Neuropsychopharmacology 35 2010 1664 1673
44. Stockhorst U., de Fries D., Steingrueber H.J., and Scherbaum W.A. Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans Physiol. Behav 83 2004 47 54
45. Stohr O., Schilbach K., Moll L., Hettich M.M., Freude S., Wunderlich F.T., and et al. Insulin receptor signaling mediates APP processing and beta-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer's disease Age (Dordr.) 35 2013 83 101
46. Yin F., Zhang Y., Guo L., Kong S., and Liu J. Geniposide regulates insulin-degrading enzyme expression to inhibit the cytotoxicity of Abeta(1)(-)(4)(2) in cortical neurons CNS Neurol. Disord. Drug Targets 11 2012 1045 1051